Real-world Study on the Effectiveness and Safety of Citicoline Sodium Capsules in the Treatment of Traumatic Brain Injury
Abstract
Objective: This study aimed to evaluate the prognostic impact of citicoline sodium capsules on patients with traumatic brain injury (TBI)and its safety. Methods: This study is a multicenter, single-arm, prospective, observational study of brain trauma patients who met the inclusion criteria between March 2023 and June 2024 and who could be treated with citicoline sodium capsules after being evaluated by the investigator. The Glasgow Coma Scale (GCS) and Mini-Mental State Examination (MMSE), the incidence of adverse drug reactions/adverse events during treatment, and the abnormalities of safety tests with clinical evaluation significance were observed at 1 month and 2 months after treatment. Results: A total of 2806 patients, 63.1% of whom were male, with an average age of 58.85 years old. The GCS and MMSE scores of the patients at 1 month and 2 months after treatment were significantly improved and were statistically significant, indicating that citicoline sodium had a significant effect on improving the state of consciousness and cognitive function of patients with TBI. Only 8 adverse reactions were reported in the study, all of which were mild gastrointestinal reactions and anaphylaxis, and did not lead to treatment interruption or serious consequences. Conclusion: Citicoline sodium has a significant therapeutic effect on patients with TBI and has good safety.
References
Zhong Y, 2018, Treatment and Prevention of Cranial Trauma. Health Road, 17(6): 124–125.
Zhou C, 2016, Analysis of 190 Cases of Disability Grade Identification of Head and Brain Injury Caused by Traffic Accidents. Chinese Journal of Forensic Medicine, 31(S1): 89–90.
Zhang W, Chen X, Wang X, et al., 2018, Zhejiang Trauma Surgery. Zhejiang Trauma Surgery, 23(3): 581–582.
Wang W, Guo F, Liao S, et al., 2012, Neuroprotective Effect of Citicoline on Spinal Cord Injury in Rats. Nerve Injury and Functional Reconstruction, 7(4): 258–262.
Sun B, 2011, Clinical Application of Citicoline in the Treatment of Vascular Cognitive Dysfunction. China Pharmacy, 22(16): 1531–1532.
Zhou C, Wu X, 2004, Research Progress of Neuroprotective Agent-Citicoline. Chinese Journal of Biochemical Drugs, (4): 255–257.
Xiao S, Fang Z, Wu F, et al., 2005, Efficacy Analysis of High-Dose Citicoline in Craniotomy for Severe Head Injury. International Medical and Health Herald, (18): 53–54.
Secades J, 2021, Role of Citicoline in the Management of Traumatic Brain Injury. Pharmaceuticals, 14(5): 410.
Javaid S, Farooq T, Rehman Z, et al., 2021, Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities. International Journal of Molecular Sciences, 22(21): 11313.
Secades J, Gareri P, 2022, Citicoline: Pharmacological and Clinical Review, 2022 Update. Revista de Neurología, 75(s05): S1–S89.
Ruan X, Cheng P, Hu G, 2021, Analysis of the Incidence and Prevalence Trend of Brain Trauma in Our Country From 2000 to 2019. Chinese Journal of Neurosurgery, 37(12): 1223–1229.
Liu C, 2018, Analysis of the Clinical Effect of Citicoline on Neurological Function Recovery in the Subacute Stage of Severe Head Injury. Huaihai Pharmaceutical, 36(1): 90–91.
Secades J, Trimmel H, Salazar B, et al., 2023, Citicoline for the Management of Patients With Traumatic Brain Injury in the Acute Phase: A Systematic Review and Meta-Analysis. Life, 13(2): 369.
